Literature DB >> 32519649

Lumbosacral Radiculopathy as the Clinical Presentation of Neurocysticercosis.

María Asunción Pérez-Jacoiste Asín1, Patricia Calleja-Castaño2, Amaya Hilario3.   

Abstract

Entities:  

Year:  2020        PMID: 32519649      PMCID: PMC7253111          DOI: 10.4269/ajtmh.19-0757

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
A 31-year-old woman from Ecuador, living in Spain since 2003, presented to our hospital in November 2017 complaining of disabling low back pain, which radiated into buttocks and lateral thighs, for 6 weeks. Spinal magnetic resonance image (MRI) demonstrated multiple intradural extramedullary cysts, the largest behind the L3 vertebral body, displacing cauda equina roots (Figure 1). With the suspicion of spinal neurocysticercosis, a diagnostic work-up was completed. Results were positive for cysticercosis serology, using a commercial ELISA to detect serum IgG antibodies to Taenia solium antigens, and also for the presence of T. solium HP10 antigen in serum, identified with a monoclonal antibody–based ELISA. Brain MRI confirmed numerous subarachnoid cysts involving basal cisterns and communicating hydrocephalus (Figure 2). When specifically asked, she noted mild headache for months. A ventriculoperitoneal shunt was placed. The analysis of the cerebrospinal fluid revealed an elevated protein concentration (1.21 g/dL) and positivity of T. solium HP10 antigen. After resolution of hydrocephalus, antiparasitic therapy was started, preceded by prednisone to control the inflammation. Because there were multiple subarachnoid cysts, she received a combination of albendazole and praziquantel for 4 weeks. Response was favourable, with persistence of mild lumbar pain, probably due to arachnoiditis, controlled with anti-inflammatory drugs. Serum T. solium antigen became negative and follow-up spinal MRI, performed 6 months later, showed clustered membranes resembling the folding of cysts after degeneration (Figure 3). After 2 years, she remained stable without symptoms or signs of recurrence.
Figure 1.

Spinal MRI: volumetric T2-weighted imaging in the sagittal plane shows a large intradural extramedullary cyst behind the L3 vertebral body (asterisk).

Figure 2.

Brain MRI volumetric T2-weighted images. Hydrocephalus (asterisk) secondary to multiple cysts involving the suprasellar region and the supravermian cistern (arrows).

Figure 3.

Spinal MRI after antiparasitic treatment; volumetric T2-weighted imaging in the sagittal plane shows clustered membranes resembling the folding of cysts (asterisk).

Spinal MRI: volumetric T2-weighted imaging in the sagittal plane shows a large intradural extramedullary cyst behind the L3 vertebral body (asterisk). Brain MRI volumetric T2-weighted images. Hydrocephalus (asterisk) secondary to multiple cysts involving the suprasellar region and the supravermian cistern (arrows). Spinal MRI after antiparasitic treatment; volumetric T2-weighted imaging in the sagittal plane shows clustered membranes resembling the folding of cysts (asterisk). Neurocysticercosis results from the ingestion of T. solium eggs shed in the stool of a human tapeworm carrier. After ingestion, oncospheres invade the intestine wall and spread hematogenously mainly to the central nervous system and muscles. Spinal neurocysticercosis occurs in 2% of all neurocysticercosis cases, and it is rare as an isolated condition.[1] When spinal subarachnoid cysts are detected, brain MRI is mandatory because of the strong association with basilar subarachnoid involvement.[2] Management of spinal neurocysticercosis should be individualized, based on symptoms, location of the cysts, degree of arachnoiditis, and surgical experience.[3] The present report is an example that medical therapy with antiparasitic agents given concomitantly with corticosteroids may be successful for subarachnoid disease of the spine. Nevertheless, combination with surgical treatment could be necessary in some cases.
  3 in total

1.  Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Authors:  A Clinton White; Christina M Coyle; Vedantam Rajshekhar; Gagandeep Singh; W Allen Hauser; Aaron Mohanty; Hector H Garcia; Theodore E Nash
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

2.  Spinal neurocysticercosis.

Authors:  George A Alsina; J Patrick Johnson; Duncan Q McBride; Patrick R L Rhoten; C Mark Mehringer; John K Stokes
Journal:  Neurosurg Focus       Date:  2002-06-15       Impact factor: 4.047

3.  High frequency of spinal involvement in patients with basal subarachnoid neurocysticercosis.

Authors:  D Callacondo; H H Garcia; I Gonzales; D Escalante; T E Nash
Journal:  Neurology       Date:  2012-04-18       Impact factor: 9.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.